Peripheral Reductive Capacity and Alzheimer's Disease
Author Information
Author(s): Minghetti Luisa, Greco Anita, Puopolo Maria, Combrinck Marc, Warden Donald, Smith A David
Primary Institution: Istituto Superiore di Sanità, Rome, Italy
Hypothesis
Is there an association between peripheral anti-oxidant capacity and cognitive performance in Alzheimer's disease patients?
Conclusion
Peripheral anti-oxidant defences are depleted in Alzheimer's disease patients, and higher serum AOC levels are associated with longer survival.
Supporting Evidence
- Serum AOC levels were lower in AD patients than in controls.
- AOC levels were correlated with cognitive test scores.
- Higher AOC levels predicted longer survival in AD patients.
Takeaway
People with Alzheimer's disease have lower levels of certain anti-oxidants in their blood, which can help predict how long they might live.
Methodology
The study measured total reductive capacity in serum samples from 26 cognitively normal controls and 25 Alzheimer's disease patients.
Limitations
The study may have been underpowered to detect associations between AOC levels and cognitive decline over time.
Participant Demographics
26 cognitively normal controls and 25 Alzheimer's disease patients, with a median age of 71.1 years.
Statistical Information
P-Value
p = 0.0098
Confidence Interval
95% C.I. = 0.12–0.97
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website